Stocks-AZN.L-AstraZeneca

AZN.L AstraZeneca

0 0 (0%)
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: AstraZeneca's revenues increased by 2.36% and amounted to 36.85B. Net income increased by 79.38% to 4.80B. Net assets decreased by 0.27% to 30.72B and EPS increased from 1.71 to 3.07.
AZN.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
72.91%
Net Profit Margin
7.55%
Operating Margin
16.13%
Return On Investment
6.02%